Rare Disease Report
Physicians
Physicians
Patients & Caregivers

Treatment for MPS I - A Patient's Perspective

FEBRUARY 15, 2017
Erika Thiel


Erika Thiel of GeneSpotlight talks about her rare disease - Mucopolysaccharidosis (MPS) 1 - and  the limitations of the currently approved enzyme replacement therapy [Aldurazyme (laronidase)].

Copyright © RareDR 2013-2017 Rare Disease Communications. All Rights Reserved.